Thomas Templeman - 01 Jul 2022 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role: Chief Technology Officer
Signature: /s/ Marella Thorell, attorney-in-fact
Issuer symbol: CNTA
Transactions as of: 01 Jul 2022
Net transactions value: $0
Form type: 4
Filing time: 06 Jul 2022, 18:15:36 UTC
Previous filing: 03 Feb 2022
Next filing: 23 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNTA	Ordinary Shares	Award	$0	+140,000	+56000%	$0.000000	140,250	01 Jul 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2	The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in 10 equal quarterly instalments with the first such quarterly vesting being on September 30, 2022.

Content

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in 10 equal quarterly instalments with the first such quarterly vesting being on September 30, 2022.